NKGN 8-K 2026-01-16

NKGen Biotech, Inc. (NKGN) 8-K dated 2026-01-16 — accession 0001213900-26-005260. This URL is the filing, not the NKGN hub.

NKGen Biotech, Inc. (NKGN) is a biotechnology company listed on US.

NKGen Biotech, Inc. filed a 8-K on 2026-01-16. Accession 0001213900-26-005260.

Cached items: 1.01, 2.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NKGN revenue for 2023-12-31 was $0. Net income was -$83.0M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. NKGN currently screens at market cap $22.4M.

Not investment advice. The NKGN SEC hub lists recent forms. The stock page is the research view.